| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Reperfusion Injury | 30 | 2016 | 1027 | 5.850 |
Why?
|
| Hindlimb | 22 | 2015 | 503 | 3.150 |
Why?
|
| Ischemia | 19 | 2016 | 1907 | 2.220 |
Why?
|
| Phenanthrenes | 8 | 2010 | 63 | 2.090 |
Why?
|
| Muscle, Skeletal | 21 | 2016 | 4925 | 1.790 |
Why?
|
| Aorta, Thoracic | 7 | 2016 | 1084 | 1.410 |
Why?
|
| Pyruvates | 2 | 2016 | 87 | 0.950 |
Why?
|
| Spinal Cord Ischemia | 2 | 2016 | 94 | 0.860 |
Why?
|
| Paralysis | 2 | 2016 | 247 | 0.840 |
Why?
|
| Health Level Seven | 1 | 2021 | 38 | 0.790 |
Why?
|
| Lower Extremity | 6 | 2019 | 1158 | 0.770 |
Why?
|
| Muscle, Smooth, Vascular | 7 | 2016 | 1503 | 0.770 |
Why?
|
| Vascular Surgical Procedures | 8 | 2014 | 1476 | 0.760 |
Why?
|
| Adenosine Triphosphate | 9 | 2015 | 2029 | 0.710 |
Why?
|
| Spinal Cord | 4 | 2016 | 1809 | 0.690 |
Why?
|
| Databases, Genetic | 2 | 2023 | 1782 | 0.650 |
Why?
|
| Neutrophils | 4 | 2015 | 3718 | 0.620 |
Why?
|
| Endothelium, Vascular | 11 | 2013 | 4459 | 0.610 |
Why?
|
| Blood Vessel Prosthesis Implantation | 7 | 2016 | 1391 | 0.580 |
Why?
|
| Disease Models, Animal | 22 | 2018 | 18027 | 0.580 |
Why?
|
| Reperfusion | 3 | 2007 | 283 | 0.570 |
Why?
|
| Military Medicine | 2 | 2011 | 176 | 0.560 |
Why?
|
| Leukocyte Reduction Procedures | 1 | 2015 | 15 | 0.550 |
Why?
|
| Genetic Variation | 2 | 2023 | 6535 | 0.550 |
Why?
|
| Myelitis | 1 | 2016 | 53 | 0.550 |
Why?
|
| Aortic Aneurysm, Abdominal | 6 | 2013 | 1187 | 0.540 |
Why?
|
| Mitochondria, Muscle | 2 | 2015 | 171 | 0.530 |
Why?
|
| Physical Conditioning, Animal | 2 | 2016 | 354 | 0.530 |
Why?
|
| Apolipoproteins E | 3 | 2013 | 1436 | 0.520 |
Why?
|
| Deoxyribonuclease I | 1 | 2015 | 229 | 0.510 |
Why?
|
| Peripheral Vascular Diseases | 7 | 2019 | 549 | 0.480 |
Why?
|
| Varicose Veins | 2 | 2016 | 154 | 0.480 |
Why?
|
| Peroxidase | 6 | 2016 | 611 | 0.470 |
Why?
|
| Regional Blood Flow | 8 | 2016 | 1525 | 0.470 |
Why?
|
| Regeneration | 4 | 2017 | 1486 | 0.460 |
Why?
|
| Tourniquets | 4 | 2008 | 110 | 0.460 |
Why?
|
| Mice, Inbred C57BL | 17 | 2016 | 21824 | 0.450 |
Why?
|
| Carotid Arteries | 4 | 2016 | 949 | 0.440 |
Why?
|
| Terminology as Topic | 1 | 2020 | 1546 | 0.430 |
Why?
|
| Apolipoproteins B | 1 | 2014 | 374 | 0.420 |
Why?
|
| Photochemotherapy | 6 | 2018 | 808 | 0.420 |
Why?
|
| Endovascular Procedures | 4 | 2015 | 1980 | 0.410 |
Why?
|
| Cytokines | 6 | 2016 | 7324 | 0.410 |
Why?
|
| Language | 1 | 2021 | 1468 | 0.400 |
Why?
|
| Arteriovenous Fistula | 2 | 2018 | 315 | 0.390 |
Why?
|
| Cell Transplantation | 1 | 2013 | 478 | 0.380 |
Why?
|
| Vascular System Injuries | 2 | 2011 | 250 | 0.380 |
Why?
|
| Animals | 55 | 2018 | 168660 | 0.370 |
Why?
|
| Femoral Artery | 8 | 2016 | 845 | 0.370 |
Why?
|
| Antithrombin III | 4 | 2015 | 128 | 0.370 |
Why?
|
| Aortic Diseases | 2 | 2015 | 743 | 0.370 |
Why?
|
| Thrombosis | 5 | 2015 | 2968 | 0.360 |
Why?
|
| Neuroprotective Agents | 1 | 2016 | 941 | 0.350 |
Why?
|
| Chemokines, CXC | 3 | 2007 | 422 | 0.350 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2013 | 567 | 0.350 |
Why?
|
| Chemokine CXCL2 | 4 | 2013 | 116 | 0.350 |
Why?
|
| Interleukin-8 | 2 | 2016 | 690 | 0.350 |
Why?
|
| Models, Genetic | 1 | 2020 | 3492 | 0.350 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2016 | 688 | 0.340 |
Why?
|
| Adaptation, Physiological | 1 | 2016 | 1311 | 0.340 |
Why?
|
| Aorta | 4 | 2015 | 2062 | 0.340 |
Why?
|
| Molecular Imaging | 1 | 2016 | 821 | 0.340 |
Why?
|
| Mice | 31 | 2016 | 81154 | 0.340 |
Why?
|
| Cyclooxygenase 2 | 2 | 2009 | 612 | 0.340 |
Why?
|
| Interleukin-6 | 7 | 2016 | 3208 | 0.330 |
Why?
|
| Mice, Inbred Strains | 6 | 2009 | 1826 | 0.330 |
Why?
|
| Carbon Monoxide | 1 | 2012 | 531 | 0.330 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2015 | 1115 | 0.330 |
Why?
|
| Aorta, Abdominal | 3 | 2011 | 646 | 0.320 |
Why?
|
| Obesity | 3 | 2016 | 12744 | 0.320 |
Why?
|
| Androstadienes | 2 | 2020 | 345 | 0.320 |
Why?
|
| Poly Adenosine Diphosphate Ribose | 2 | 2005 | 49 | 0.310 |
Why?
|
| Poly(ADP-ribose) Polymerases | 2 | 2006 | 437 | 0.310 |
Why?
|
| Diphosphonates | 1 | 2012 | 622 | 0.310 |
Why?
|
| Thrombophlebitis | 1 | 2008 | 309 | 0.300 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 7 | 2016 | 3874 | 0.300 |
Why?
|
| Extracellular Matrix | 6 | 2017 | 1743 | 0.300 |
Why?
|
| Aortic Aneurysm, Thoracic | 2 | 2015 | 691 | 0.300 |
Why?
|
| Carotid Artery Diseases | 1 | 2014 | 875 | 0.300 |
Why?
|
| Peptide Hydrolases | 4 | 2015 | 633 | 0.300 |
Why?
|
| Venous Insufficiency | 1 | 2008 | 103 | 0.290 |
Why?
|
| Wounds, Gunshot | 2 | 2009 | 563 | 0.290 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2016 | 1789 | 0.290 |
Why?
|
| Laser-Doppler Flowmetry | 6 | 2012 | 242 | 0.280 |
Why?
|
| Inflammation | 6 | 2016 | 10629 | 0.280 |
Why?
|
| Edema | 2 | 2008 | 789 | 0.280 |
Why?
|
| Imidazoles | 1 | 2012 | 1206 | 0.280 |
Why?
|
| Prostaglandins | 4 | 2001 | 405 | 0.280 |
Why?
|
| Stents | 4 | 2015 | 3280 | 0.270 |
Why?
|
| Oxygen | 8 | 2019 | 4189 | 0.270 |
Why?
|
| Endothelial Cells | 3 | 2016 | 3482 | 0.270 |
Why?
|
| Monokines | 1 | 2005 | 79 | 0.270 |
Why?
|
| Enoxaparin | 1 | 2008 | 377 | 0.260 |
Why?
|
| Bone Density Conservation Agents | 1 | 2012 | 768 | 0.260 |
Why?
|
| Tunica Intima | 3 | 2018 | 463 | 0.260 |
Why?
|
| Hypothermia, Induced | 1 | 2010 | 752 | 0.250 |
Why?
|
| Arteriovenous Shunt, Surgical | 3 | 2018 | 277 | 0.250 |
Why?
|
| Photosensitizing Agents | 4 | 2018 | 602 | 0.250 |
Why?
|
| Alprostadil | 1 | 2004 | 89 | 0.240 |
Why?
|
| Chemokine CXCL1 | 3 | 2010 | 101 | 0.240 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 4 | 2004 | 329 | 0.240 |
Why?
|
| Iliac Artery | 3 | 2015 | 364 | 0.240 |
Why?
|
| Surgery Department, Hospital | 1 | 2005 | 175 | 0.220 |
Why?
|
| Time Factors | 24 | 2020 | 40038 | 0.220 |
Why?
|
| RNA | 1 | 2013 | 2748 | 0.220 |
Why?
|
| DNA | 2 | 2014 | 7295 | 0.220 |
Why?
|
| Fibroblast Growth Factor 2 | 2 | 2012 | 599 | 0.210 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2014 | 1518 | 0.210 |
Why?
|
| Spinal Cord Diseases | 1 | 2005 | 298 | 0.200 |
Why?
|
| Cells, Cultured | 18 | 2016 | 19232 | 0.200 |
Why?
|
| Receptors, Prostaglandin E | 1 | 2001 | 56 | 0.200 |
Why?
|
| Inflammation Mediators | 3 | 2016 | 1888 | 0.200 |
Why?
|
| Hypercholesterolemia | 1 | 2008 | 1151 | 0.200 |
Why?
|
| Male | 57 | 2020 | 349776 | 0.200 |
Why?
|
| Mitochondria | 3 | 2009 | 3513 | 0.190 |
Why?
|
| Intermittent Claudication | 4 | 2010 | 309 | 0.190 |
Why?
|
| Cell Hypoxia | 4 | 1999 | 675 | 0.190 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2006 | 612 | 0.190 |
Why?
|
| Logical Observation Identifiers Names and Codes | 1 | 2020 | 17 | 0.190 |
Why?
|
| Systematized Nomenclature of Medicine | 1 | 2020 | 36 | 0.190 |
Why?
|
| Saphenous Vein | 3 | 2016 | 532 | 0.190 |
Why?
|
| Dinoprost | 2 | 1999 | 138 | 0.180 |
Why?
|
| RNA, Messenger | 8 | 2009 | 13028 | 0.180 |
Why?
|
| Chlorobenzenes | 1 | 2020 | 28 | 0.180 |
Why?
|
| Benzyl Alcohols | 1 | 2020 | 29 | 0.180 |
Why?
|
| Professional Practice Location | 1 | 2020 | 58 | 0.180 |
Why?
|
| Arachidonic Acid | 4 | 1997 | 434 | 0.180 |
Why?
|
| Limb Salvage | 3 | 2018 | 433 | 0.170 |
Why?
|
| Immunohistochemistry | 6 | 2016 | 11360 | 0.170 |
Why?
|
| Macrophages | 1 | 2014 | 5651 | 0.170 |
Why?
|
| Adrenergic beta-2 Receptor Agonists | 1 | 2020 | 103 | 0.170 |
Why?
|
| Wound Healing | 3 | 2017 | 2776 | 0.170 |
Why?
|
| Blood Substitutes | 1 | 2019 | 58 | 0.170 |
Why?
|
| Angioplasty, Balloon | 3 | 2009 | 653 | 0.170 |
Why?
|
| Rose Bengal | 2 | 2016 | 116 | 0.160 |
Why?
|
| Carbamates | 1 | 2020 | 196 | 0.160 |
Why?
|
| Genome, Human | 2 | 2023 | 4418 | 0.160 |
Why?
|
| Penis | 4 | 2002 | 214 | 0.160 |
Why?
|
| Leg | 4 | 2018 | 1116 | 0.160 |
Why?
|
| Neointima | 2 | 2016 | 135 | 0.160 |
Why?
|
| Administration, Inhalation | 3 | 2020 | 1105 | 0.160 |
Why?
|
| Schools, Medical | 1 | 2005 | 879 | 0.160 |
Why?
|
| Arterial Occlusive Diseases | 3 | 2009 | 793 | 0.160 |
Why?
|
| Oxyhemoglobins | 1 | 2019 | 216 | 0.160 |
Why?
|
| Intestinal Mucosa | 1 | 2009 | 3038 | 0.150 |
Why?
|
| Popliteal Artery | 3 | 2009 | 317 | 0.150 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2016 | 11729 | 0.150 |
Why?
|
| Receptors, Cell Surface | 1 | 2007 | 2865 | 0.150 |
Why?
|
| Muscle, Smooth | 1 | 2001 | 934 | 0.150 |
Why?
|
| Anticoagulants | 3 | 2014 | 4599 | 0.150 |
Why?
|
| Vasoconstriction | 2 | 2019 | 597 | 0.150 |
Why?
|
| Tissue Survival | 2 | 2009 | 118 | 0.140 |
Why?
|
| Constriction | 1 | 2016 | 181 | 0.140 |
Why?
|
| Quinolones | 1 | 2020 | 368 | 0.140 |
Why?
|
| Atherosclerosis | 1 | 2013 | 3445 | 0.140 |
Why?
|
| Liver | 2 | 2010 | 7479 | 0.140 |
Why?
|
| Neonatal Screening | 1 | 2021 | 590 | 0.140 |
Why?
|
| Venous Pressure | 1 | 2016 | 56 | 0.140 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 3 | 2020 | 3047 | 0.140 |
Why?
|
| Endarterectomy, Carotid | 3 | 2006 | 546 | 0.140 |
Why?
|
| Angiogenic Proteins | 1 | 2016 | 104 | 0.140 |
Why?
|
| Reactive Oxygen Species | 4 | 2013 | 2077 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2015 | 2504 | 0.130 |
Why?
|
| Electroporation | 1 | 2017 | 251 | 0.130 |
Why?
|
| Humans | 62 | 2024 | 743811 | 0.130 |
Why?
|
| Kidney Diseases | 2 | 2010 | 2146 | 0.130 |
Why?
|
| Microcirculation | 4 | 2010 | 1287 | 0.130 |
Why?
|
| Brachial Artery | 3 | 2007 | 369 | 0.130 |
Why?
|
| Cell Proliferation | 4 | 2016 | 10477 | 0.120 |
Why?
|
| Cell Survival | 5 | 2010 | 5881 | 0.120 |
Why?
|
| Popliteal Vein | 1 | 2014 | 43 | 0.120 |
Why?
|
| Rejuvenation | 1 | 2015 | 91 | 0.120 |
Why?
|
| Glyceraldehyde 3-Phosphate Dehydrogenase (NADP+) | 1 | 2013 | 5 | 0.120 |
Why?
|
| Extracellular Matrix Proteins | 2 | 2016 | 850 | 0.120 |
Why?
|
| Lactates | 2 | 2011 | 431 | 0.120 |
Why?
|
| Lung | 3 | 2020 | 9858 | 0.120 |
Why?
|
| Cytochrome b Group | 1 | 2013 | 60 | 0.120 |
Why?
|
| Choice Behavior | 1 | 2020 | 802 | 0.120 |
Why?
|
| Carotid Stenosis | 3 | 2006 | 854 | 0.120 |
Why?
|
| Aortic Rupture | 2 | 2015 | 312 | 0.120 |
Why?
|
| Mice, Knockout | 6 | 2016 | 14563 | 0.120 |
Why?
|
| Anastomotic Leak | 1 | 2015 | 162 | 0.110 |
Why?
|
| Hyperplasia | 5 | 2018 | 1185 | 0.110 |
Why?
|
| Syndecan-4 | 2 | 2012 | 44 | 0.110 |
Why?
|
| Vascular Endothelial Growth Factor A | 3 | 2013 | 3510 | 0.110 |
Why?
|
| Cosmetic Techniques | 1 | 2015 | 135 | 0.110 |
Why?
|
| Postoperative Complications | 9 | 2016 | 15281 | 0.110 |
Why?
|
| Carotid Artery Injuries | 1 | 2013 | 96 | 0.110 |
Why?
|
| Capillaries | 1 | 2016 | 773 | 0.110 |
Why?
|
| Protein Prenylation | 1 | 2012 | 73 | 0.110 |
Why?
|
| Blood Vessel Prosthesis | 4 | 2003 | 933 | 0.110 |
Why?
|
| Aortic Coarctation | 1 | 2015 | 281 | 0.110 |
Why?
|
| Cross-Linking Reagents | 1 | 2016 | 694 | 0.110 |
Why?
|
| rap1 GTP-Binding Proteins | 1 | 2012 | 60 | 0.110 |
Why?
|
| Analysis of Variance | 3 | 2012 | 6356 | 0.110 |
Why?
|
| Carotid Artery, Common | 1 | 2013 | 183 | 0.110 |
Why?
|
| Epoprostenol | 5 | 1997 | 254 | 0.110 |
Why?
|
| Vena Cava Filters | 2 | 2012 | 253 | 0.110 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 2013 | 174 | 0.110 |
Why?
|
| Delivery of Health Care | 2 | 2021 | 5319 | 0.110 |
Why?
|
| Epidermis | 1 | 2015 | 529 | 0.100 |
Why?
|
| Cattle | 6 | 1997 | 3917 | 0.100 |
Why?
|
| STAT3 Transcription Factor | 1 | 2016 | 873 | 0.100 |
Why?
|
| Proteolipids | 1 | 2012 | 117 | 0.100 |
Why?
|
| Ligation | 2 | 2010 | 452 | 0.100 |
Why?
|
| Veins | 1 | 2016 | 770 | 0.100 |
Why?
|
| Kidney | 4 | 2010 | 7185 | 0.100 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2006 | 3537 | 0.100 |
Why?
|
| Myxoma | 1 | 1992 | 130 | 0.100 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2016 | 1157 | 0.100 |
Why?
|
| Aneurysm | 1 | 2014 | 339 | 0.100 |
Why?
|
| Blood Gas Analysis | 1 | 2012 | 383 | 0.100 |
Why?
|
| Blood Flow Velocity | 4 | 2010 | 1423 | 0.100 |
Why?
|
| Deoxyribonucleases | 1 | 2012 | 214 | 0.100 |
Why?
|
| Anterior Horn Cells | 1 | 2010 | 19 | 0.090 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2020 | 1854 | 0.090 |
Why?
|
| Extremities | 1 | 2016 | 867 | 0.090 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2018 | 8300 | 0.090 |
Why?
|
| Cell Movement | 3 | 2012 | 5216 | 0.090 |
Why?
|
| Dinoprostone | 3 | 2004 | 601 | 0.090 |
Why?
|
| Liver, Artificial | 1 | 2010 | 56 | 0.090 |
Why?
|
| Paraplegia | 1 | 2011 | 169 | 0.090 |
Why?
|
| Poloxamer | 1 | 2010 | 57 | 0.090 |
Why?
|
| Ion Channels | 1 | 2015 | 1056 | 0.090 |
Why?
|
| Multicenter Studies as Topic | 1 | 2015 | 1676 | 0.090 |
Why?
|
| Hyperemia | 2 | 2010 | 225 | 0.090 |
Why?
|
| Hemostatic Techniques | 1 | 2011 | 116 | 0.090 |
Why?
|
| Nitric Oxide | 1 | 2019 | 2132 | 0.090 |
Why?
|
| Renal Dialysis | 3 | 2016 | 1783 | 0.090 |
Why?
|
| Surface-Active Agents | 1 | 2010 | 159 | 0.090 |
Why?
|
| Heme Oxygenase-1 | 1 | 2012 | 381 | 0.090 |
Why?
|
| Anemia | 1 | 2019 | 1502 | 0.090 |
Why?
|
| Electric Stimulation Therapy | 1 | 2015 | 605 | 0.080 |
Why?
|
| Biomedical Research | 1 | 2005 | 3308 | 0.080 |
Why?
|
| MAP Kinase Signaling System | 1 | 2016 | 1524 | 0.080 |
Why?
|
| Flow Cytometry | 2 | 2016 | 5973 | 0.080 |
Why?
|
| Buttocks | 1 | 2009 | 110 | 0.080 |
Why?
|
| Female | 38 | 2020 | 380020 | 0.080 |
Why?
|
| Mitochondrial Proteins | 1 | 2015 | 993 | 0.080 |
Why?
|
| Muscle Contraction | 1 | 2014 | 1233 | 0.080 |
Why?
|
| Alleles | 1 | 2020 | 6934 | 0.080 |
Why?
|
| Myogenin | 1 | 2008 | 58 | 0.080 |
Why?
|
| Mutation | 1 | 2013 | 29777 | 0.080 |
Why?
|
| Skin | 2 | 2017 | 4372 | 0.080 |
Why?
|
| Heart Neoplasms | 1 | 1992 | 374 | 0.080 |
Why?
|
| Transforming Growth Factor beta | 2 | 2011 | 2006 | 0.080 |
Why?
|
| Adipocytes | 1 | 2015 | 1182 | 0.080 |
Why?
|
| Actins | 1 | 2015 | 2121 | 0.080 |
Why?
|
| Microscopy, Confocal | 1 | 2014 | 1962 | 0.080 |
Why?
|
| Renal Artery Obstruction | 2 | 2012 | 248 | 0.080 |
Why?
|
| MyoD Protein | 1 | 2008 | 151 | 0.080 |
Why?
|
| Prosthesis Implantation | 1 | 2012 | 640 | 0.080 |
Why?
|
| Subclavian Artery | 1 | 1988 | 130 | 0.080 |
Why?
|
| Treatment Outcome | 17 | 2020 | 63042 | 0.080 |
Why?
|
| Internet | 1 | 2020 | 3058 | 0.080 |
Why?
|
| Craniocerebral Trauma | 1 | 1992 | 482 | 0.080 |
Why?
|
| Receptors, CCR2 | 1 | 2008 | 212 | 0.070 |
Why?
|
| Random Allocation | 1 | 2012 | 2429 | 0.070 |
Why?
|
| Vascular Patency | 3 | 2016 | 887 | 0.070 |
Why?
|
| Physical Exertion | 1 | 2010 | 695 | 0.070 |
Why?
|
| Autophagy | 1 | 2015 | 1296 | 0.070 |
Why?
|
| Interleukin-1 | 1 | 2011 | 1263 | 0.070 |
Why?
|
| Locomotion | 1 | 2009 | 378 | 0.070 |
Why?
|
| Cell Adhesion | 2 | 2012 | 3144 | 0.070 |
Why?
|
| Neurologic Examination | 1 | 2010 | 929 | 0.070 |
Why?
|
| Disease Progression | 2 | 2014 | 13273 | 0.070 |
Why?
|
| Bone Density | 1 | 2020 | 3460 | 0.070 |
Why?
|
| Osteopontin | 1 | 2008 | 294 | 0.070 |
Why?
|
| Patient Discharge | 1 | 2019 | 3317 | 0.070 |
Why?
|
| Trans-Activators | 1 | 2016 | 2927 | 0.070 |
Why?
|
| Heart Failure | 3 | 2013 | 10896 | 0.070 |
Why?
|
| Health Resources | 1 | 2013 | 912 | 0.070 |
Why?
|
| Tail | 1 | 2006 | 97 | 0.070 |
Why?
|
| Stress, Physiological | 1 | 2014 | 1403 | 0.070 |
Why?
|
| Cytoskeletal Proteins | 1 | 2012 | 1364 | 0.070 |
Why?
|
| Healthcare Disparities | 2 | 2020 | 3155 | 0.070 |
Why?
|
| Ultrasonography, Doppler, Pulsed | 2 | 2003 | 19 | 0.070 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2009 | 549 | 0.070 |
Why?
|
| Injections, Intravenous | 1 | 2008 | 1422 | 0.070 |
Why?
|
| Recombinant Proteins | 1 | 2015 | 6620 | 0.070 |
Why?
|
| Thoracic Arteries | 1 | 2005 | 41 | 0.070 |
Why?
|
| Chemokines | 1 | 2010 | 968 | 0.070 |
Why?
|
| Forecasting | 1 | 2015 | 2950 | 0.070 |
Why?
|
| Aged | 29 | 2020 | 163178 | 0.070 |
Why?
|
| Suture Techniques | 1 | 2011 | 797 | 0.070 |
Why?
|
| Software | 1 | 2020 | 4440 | 0.070 |
Why?
|
| Chemokine CCL2 | 1 | 2008 | 620 | 0.070 |
Why?
|
| Groin | 1 | 2005 | 105 | 0.070 |
Why?
|
| Receptors, Leptin | 1 | 2007 | 361 | 0.060 |
Why?
|
| Patient Selection | 4 | 2016 | 4210 | 0.060 |
Why?
|
| Repressor Proteins | 1 | 2016 | 3024 | 0.060 |
Why?
|
| Superoxide Dismutase | 2 | 1999 | 595 | 0.060 |
Why?
|
| Binding Sites | 1 | 2014 | 6111 | 0.060 |
Why?
|
| Lactic Acid | 2 | 2004 | 1131 | 0.060 |
Why?
|
| Risk Assessment | 6 | 2019 | 23327 | 0.060 |
Why?
|
| Phosphorylation | 1 | 2016 | 8436 | 0.060 |
Why?
|
| Arm | 1 | 1988 | 588 | 0.060 |
Why?
|
| Microfluidics | 1 | 2010 | 662 | 0.060 |
Why?
|
| Insulin Resistance | 2 | 2016 | 3863 | 0.060 |
Why?
|
| Drug Combinations | 2 | 2020 | 1958 | 0.060 |
Why?
|
| Cholesterol | 2 | 2008 | 2922 | 0.060 |
Why?
|
| Aged, 80 and over | 14 | 2019 | 57744 | 0.060 |
Why?
|
| Lipocalins | 1 | 2005 | 170 | 0.060 |
Why?
|
| Middle Aged | 25 | 2020 | 213241 | 0.060 |
Why?
|
| Injections, Intraperitoneal | 1 | 2005 | 424 | 0.060 |
Why?
|
| DNA Mutational Analysis | 1 | 2013 | 4183 | 0.060 |
Why?
|
| Electronic Health Records | 1 | 2021 | 4467 | 0.060 |
Why?
|
| Health Status Indicators | 1 | 2010 | 970 | 0.060 |
Why?
|
| Fibrinolysis | 1 | 2005 | 322 | 0.060 |
Why?
|
| Cyclooxygenase 1 | 1 | 2004 | 104 | 0.060 |
Why?
|
| Acute-Phase Proteins | 1 | 2005 | 262 | 0.060 |
Why?
|
| Cell Count | 3 | 1996 | 1855 | 0.060 |
Why?
|
| Body Weight | 1 | 2015 | 4670 | 0.060 |
Why?
|
| Durable Medical Equipment | 1 | 2003 | 22 | 0.060 |
Why?
|
| Hepatocytes | 1 | 2010 | 1211 | 0.060 |
Why?
|
| Severity of Illness Index | 3 | 2013 | 15526 | 0.060 |
Why?
|
| Renal Insufficiency | 2 | 2013 | 805 | 0.060 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2005 | 426 | 0.060 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2011 | 1874 | 0.060 |
Why?
|
| Hernia | 1 | 2003 | 70 | 0.060 |
Why?
|
| Kidney Failure, Chronic | 1 | 2016 | 2534 | 0.060 |
Why?
|
| Angioplasty | 1 | 2006 | 364 | 0.060 |
Why?
|
| Receptors, Prostaglandin | 1 | 2002 | 57 | 0.060 |
Why?
|
| Risk Factors | 13 | 2019 | 72252 | 0.050 |
Why?
|
| Materials Testing | 1 | 2006 | 866 | 0.050 |
Why?
|
| NAD | 1 | 2006 | 590 | 0.050 |
Why?
|
| Peripheral Arterial Disease | 1 | 2013 | 1188 | 0.050 |
Why?
|
| Thrombolytic Therapy | 1 | 2012 | 2162 | 0.050 |
Why?
|
| Umbilical Arteries | 2 | 1999 | 75 | 0.050 |
Why?
|
| Equipment Design | 2 | 2011 | 3574 | 0.050 |
Why?
|
| Survivors | 1 | 2013 | 2291 | 0.050 |
Why?
|
| Fibrinolytic Agents | 1 | 2012 | 2159 | 0.050 |
Why?
|
| Catalase | 2 | 1999 | 221 | 0.050 |
Why?
|
| Hemorrhage | 2 | 2011 | 3458 | 0.050 |
Why?
|
| Reproducibility of Results | 4 | 2016 | 19894 | 0.050 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2003 | 214 | 0.050 |
Why?
|
| Immunoenzyme Techniques | 1 | 2005 | 1799 | 0.050 |
Why?
|
| Renal Artery | 1 | 2004 | 399 | 0.050 |
Why?
|
| Histones | 1 | 2012 | 2598 | 0.050 |
Why?
|
| Insulin | 1 | 2016 | 6584 | 0.050 |
Why?
|
| Proportional Hazards Models | 7 | 2013 | 12354 | 0.050 |
Why?
|
| Odds Ratio | 5 | 2016 | 9848 | 0.050 |
Why?
|
| Rats | 5 | 2018 | 24250 | 0.050 |
Why?
|
| Lipids | 2 | 2005 | 3307 | 0.050 |
Why?
|
| Neutrophil Infiltration | 1 | 2004 | 390 | 0.050 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2004 | 595 | 0.050 |
Why?
|
| Kaplan-Meier Estimate | 4 | 2016 | 6539 | 0.050 |
Why?
|
| Oncogene Proteins | 1 | 2005 | 749 | 0.050 |
Why?
|
| Heparin | 1 | 2008 | 1637 | 0.050 |
Why?
|
| Infant, Newborn | 1 | 2021 | 25609 | 0.050 |
Why?
|
| Laparotomy | 1 | 2003 | 473 | 0.050 |
Why?
|
| Interleukin-1beta | 1 | 2006 | 973 | 0.050 |
Why?
|
| Hernia, Ventral | 1 | 2003 | 176 | 0.050 |
Why?
|
| Autocrine Communication | 1 | 2001 | 171 | 0.050 |
Why?
|
| Mice, Transgenic | 1 | 2013 | 9731 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2009 | 3917 | 0.050 |
Why?
|
| Blotting, Western | 1 | 2008 | 5179 | 0.050 |
Why?
|
| Apoptosis | 1 | 2016 | 9718 | 0.050 |
Why?
|
| Signal Transduction | 3 | 2016 | 23398 | 0.050 |
Why?
|
| Venous Thromboembolism | 1 | 2012 | 1670 | 0.040 |
Why?
|
| Vasodilation | 4 | 2007 | 944 | 0.040 |
Why?
|
| Motor Neurons | 1 | 2005 | 841 | 0.040 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2013 | 2200 | 0.040 |
Why?
|
| Nebulizers and Vaporizers | 1 | 2020 | 139 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 1 | 2009 | 6170 | 0.040 |
Why?
|
| Isoenzymes | 1 | 2004 | 1728 | 0.040 |
Why?
|
| Indomethacin | 1 | 1999 | 332 | 0.040 |
Why?
|
| Arteriosclerosis | 1 | 2004 | 1092 | 0.040 |
Why?
|
| Embolization, Therapeutic | 1 | 2009 | 1392 | 0.040 |
Why?
|
| Clinical Trials as Topic | 1 | 2015 | 7908 | 0.040 |
Why?
|
| Protozoan Proteins | 1 | 2005 | 825 | 0.040 |
Why?
|
| Free Radical Scavengers | 1 | 1999 | 216 | 0.040 |
Why?
|
| Partial Pressure | 2 | 1997 | 254 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2015 | 9944 | 0.040 |
Why?
|
| Chi-Square Distribution | 2 | 2016 | 3503 | 0.040 |
Why?
|
| Rehabilitation Centers | 1 | 2019 | 253 | 0.040 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 1999 | 371 | 0.040 |
Why?
|
| Foot Ulcer | 1 | 1998 | 59 | 0.040 |
Why?
|
| COS Cells | 1 | 1999 | 1161 | 0.040 |
Why?
|
| New York City | 1 | 2020 | 705 | 0.040 |
Why?
|
| Radioisotope Dilution Technique | 1 | 1997 | 70 | 0.040 |
Why?
|
| Sympathectomy | 1 | 1998 | 89 | 0.040 |
Why?
|
| Cholesterol Esters | 1 | 1997 | 74 | 0.040 |
Why?
|
| Glycerides | 1 | 1997 | 71 | 0.040 |
Why?
|
| Reoperation | 3 | 2013 | 4200 | 0.040 |
Why?
|
| Boston | 3 | 2016 | 9310 | 0.040 |
Why?
|
| History, 20th Century | 1 | 2005 | 2736 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2012 | 14714 | 0.040 |
Why?
|
| DNA Damage | 1 | 2006 | 2429 | 0.040 |
Why?
|
| Compliance | 1 | 2016 | 104 | 0.030 |
Why?
|
| Receptors, Immunologic | 1 | 2002 | 1423 | 0.030 |
Why?
|
| Hydrogen Peroxide | 1 | 1999 | 730 | 0.030 |
Why?
|
| Databases as Topic | 2 | 2010 | 474 | 0.030 |
Why?
|
| Double-Blind Method | 2 | 2020 | 12020 | 0.030 |
Why?
|
| Cell Culture Techniques | 2 | 2010 | 1677 | 0.030 |
Why?
|
| Carbon Radioisotopes | 1 | 1997 | 577 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2006 | 3794 | 0.030 |
Why?
|
| Genomics | 1 | 2011 | 5714 | 0.030 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2016 | 286 | 0.030 |
Why?
|
| Prospective Studies | 7 | 2020 | 53250 | 0.030 |
Why?
|
| Antimetabolites | 1 | 1996 | 125 | 0.030 |
Why?
|
| Skilled Nursing Facilities | 1 | 2019 | 372 | 0.030 |
Why?
|
| Comorbidity | 3 | 2016 | 10380 | 0.030 |
Why?
|
| Information Dissemination | 1 | 2024 | 1099 | 0.030 |
Why?
|
| Thromboxanes | 1 | 1995 | 50 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2012 | 20121 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2007 | 4422 | 0.030 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 1997 | 402 | 0.030 |
Why?
|
| Forced Expiratory Volume | 1 | 2020 | 1740 | 0.030 |
Why?
|
| Follow-Up Studies | 9 | 2009 | 39001 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2005 | 2922 | 0.030 |
Why?
|
| Retrospective Studies | 11 | 2016 | 77410 | 0.030 |
Why?
|
| Sus scrofa | 1 | 2016 | 438 | 0.030 |
Why?
|
| Electrodes | 1 | 2017 | 616 | 0.030 |
Why?
|
| Age Factors | 4 | 2016 | 18355 | 0.030 |
Why?
|
| Neoplasms | 1 | 2024 | 21675 | 0.030 |
Why?
|
| Vascular Grafting | 1 | 2016 | 143 | 0.030 |
Why?
|
| Dilatation, Pathologic | 1 | 2016 | 520 | 0.030 |
Why?
|
| Elasticity | 1 | 2016 | 657 | 0.030 |
Why?
|
| Canada | 1 | 2020 | 2064 | 0.030 |
Why?
|
| Pentoxifylline | 1 | 1994 | 55 | 0.030 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein Group C | 1 | 2013 | 14 | 0.030 |
Why?
|
| Matrix Metalloproteinase 12 | 1 | 2013 | 48 | 0.030 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 1995 | 424 | 0.030 |
Why?
|
| Casein Kinase Ialpha | 1 | 2013 | 27 | 0.030 |
Why?
|
| Culture Media | 1 | 1996 | 909 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2009 | 12954 | 0.030 |
Why?
|
| Elastic Tissue | 1 | 2013 | 65 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2009 | 13980 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2016 | 1800 | 0.030 |
Why?
|
| Phospholipids | 1 | 1997 | 784 | 0.030 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2013 | 148 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2009 | 9440 | 0.030 |
Why?
|
| Multivariate Analysis | 3 | 2013 | 12243 | 0.030 |
Why?
|
| Europe | 1 | 2020 | 3336 | 0.030 |
Why?
|
| Aspirin | 2 | 1999 | 3283 | 0.030 |
Why?
|
| United States | 5 | 2020 | 69859 | 0.030 |
Why?
|
| Recurrence | 3 | 2014 | 8337 | 0.030 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2016 | 627 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2007 | 6259 | 0.030 |
Why?
|
| Hypertension, Renovascular | 1 | 2012 | 123 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 1999 | 2203 | 0.030 |
Why?
|
| Cardiovascular Diseases | 3 | 2007 | 15142 | 0.030 |
Why?
|
| Respiration | 1 | 2019 | 1653 | 0.030 |
Why?
|
| Proteoglycans | 1 | 1995 | 837 | 0.030 |
Why?
|
| Angiography | 2 | 2009 | 1638 | 0.030 |
Why?
|
| Medical Oncology | 1 | 2024 | 2267 | 0.030 |
Why?
|
| Survival Rate | 4 | 2009 | 12786 | 0.030 |
Why?
|
| Prosthesis Design | 2 | 2012 | 2103 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2020 | 4931 | 0.020 |
Why?
|
| Logistic Models | 3 | 2016 | 13404 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 1997 | 1684 | 0.020 |
Why?
|
| Heart Defects, Congenital | 1 | 1988 | 4584 | 0.020 |
Why?
|
| Accidental Falls | 1 | 1999 | 1062 | 0.020 |
Why?
|
| Angiography, Digital Subtraction | 1 | 2012 | 341 | 0.020 |
Why?
|
| Ureteral Obstruction | 1 | 2012 | 296 | 0.020 |
Why?
|
| Patient Participation | 1 | 2020 | 1457 | 0.020 |
Why?
|
| Quality of Health Care | 1 | 2006 | 4370 | 0.020 |
Why?
|
| Wrist | 1 | 1992 | 223 | 0.020 |
Why?
|
| Cell Death | 1 | 1996 | 1705 | 0.020 |
Why?
|
| Adult | 10 | 2019 | 213889 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2016 | 1783 | 0.020 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2005 | 3255 | 0.020 |
Why?
|
| Glasgow Coma Scale | 1 | 1992 | 570 | 0.020 |
Why?
|
| Arteries | 2 | 1992 | 1119 | 0.020 |
Why?
|
| Pulmonary Embolism | 2 | 2014 | 2375 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2011 | 17439 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2016 | 1156 | 0.020 |
Why?
|
| Ischemic Preconditioning | 1 | 2010 | 92 | 0.020 |
Why?
|
| Cell Line | 1 | 2004 | 15993 | 0.020 |
Why?
|
| Punctures | 1 | 2011 | 374 | 0.020 |
Why?
|
| Bioreactors | 1 | 2010 | 236 | 0.020 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 1994 | 632 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 35409 | 0.020 |
Why?
|
| Life Expectancy | 1 | 2016 | 1184 | 0.020 |
Why?
|
| Kinetics | 1 | 1997 | 6476 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2016 | 3000 | 0.020 |
Why?
|
| Heart Diseases | 1 | 2002 | 2789 | 0.020 |
Why?
|
| Rats, Inbred Lew | 1 | 2010 | 1162 | 0.020 |
Why?
|
| Critical Illness | 2 | 2013 | 2670 | 0.020 |
Why?
|
| Back Pain | 1 | 2012 | 544 | 0.020 |
Why?
|
| Endothelium | 2 | 1997 | 777 | 0.020 |
Why?
|
| Surgical Flaps | 1 | 1997 | 1629 | 0.020 |
Why?
|
| Dextrans | 1 | 2010 | 595 | 0.020 |
Why?
|
| Cell Division | 3 | 1997 | 4568 | 0.020 |
Why?
|
| Graft Survival | 2 | 2016 | 3734 | 0.020 |
Why?
|
| Blood Gas Monitoring, Transcutaneous | 2 | 1998 | 34 | 0.020 |
Why?
|
| Radiography | 2 | 2011 | 7010 | 0.020 |
Why?
|
| Collagen | 1 | 2016 | 2681 | 0.020 |
Why?
|
| Methods | 1 | 2007 | 1128 | 0.020 |
Why?
|
| Device Removal | 1 | 2012 | 655 | 0.020 |
Why?
|
| Insurance, Health | 1 | 2020 | 2492 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2004 | 7880 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2016 | 3504 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2016 | 21733 | 0.020 |
Why?
|
| Muscle Cells | 1 | 2007 | 197 | 0.020 |
Why?
|
| Medicaid | 1 | 2020 | 2736 | 0.020 |
Why?
|
| Head | 1 | 1992 | 878 | 0.020 |
Why?
|
| Wounds and Injuries | 1 | 1999 | 2401 | 0.020 |
Why?
|
| Swine | 1 | 2016 | 5909 | 0.020 |
Why?
|
| Abdominal Pain | 1 | 2012 | 1064 | 0.020 |
Why?
|
| Hospitals, Private | 1 | 2006 | 63 | 0.020 |
Why?
|
| Heart Atria | 1 | 1992 | 1357 | 0.020 |
Why?
|
| Tibial Arteries | 1 | 2005 | 57 | 0.020 |
Why?
|
| Ultrasonography | 2 | 2010 | 5986 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 1996 | 3082 | 0.020 |
Why?
|
| Transfection | 1 | 2013 | 5892 | 0.020 |
Why?
|
| RNA Interference | 1 | 2013 | 2890 | 0.020 |
Why?
|
| Anastomosis, Surgical | 1 | 1988 | 987 | 0.020 |
Why?
|
| Constriction, Pathologic | 1 | 1988 | 1108 | 0.020 |
Why?
|
| Ultrasonography, Doppler, Duplex | 1 | 2005 | 205 | 0.020 |
Why?
|
| Length of Stay | 2 | 2013 | 6311 | 0.010 |
Why?
|
| Microbial Collagenase | 1 | 1984 | 122 | 0.010 |
Why?
|
| Femur | 1 | 2010 | 1296 | 0.010 |
Why?
|
| Probability | 1 | 2009 | 2505 | 0.010 |
Why?
|
| Organ Culture Techniques | 2 | 1996 | 813 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 1995 | 5867 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 2009 | 2971 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2009 | 2883 | 0.010 |
Why?
|
| Disease Management | 1 | 2014 | 2459 | 0.010 |
Why?
|
| Hospitals, Veterans | 1 | 2006 | 404 | 0.010 |
Why?
|
| Decision Support Techniques | 1 | 2013 | 1956 | 0.010 |
Why?
|
| Hydantoins | 1 | 2002 | 11 | 0.010 |
Why?
|
| Serotonin | 1 | 1987 | 1017 | 0.010 |
Why?
|
| Anesthesia, Conduction | 1 | 2006 | 238 | 0.010 |
Why?
|
| Proteomics | 1 | 2016 | 3639 | 0.010 |
Why?
|
| Predictive Value of Tests | 2 | 2010 | 15067 | 0.010 |
Why?
|
| Organometallic Compounds | 2 | 1997 | 665 | 0.010 |
Why?
|
| Diabetes Complications | 1 | 2010 | 1360 | 0.010 |
Why?
|
| Adolescent | 4 | 2018 | 85729 | 0.010 |
Why?
|
| Monocytes | 1 | 2012 | 2593 | 0.010 |
Why?
|
| Disease-Free Survival | 2 | 2004 | 6895 | 0.010 |
Why?
|
| Coronary Vessels | 1 | 2013 | 3106 | 0.010 |
Why?
|
| Medicare | 1 | 2020 | 6565 | 0.010 |
Why?
|
| Kidney Function Tests | 1 | 2004 | 684 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 1992 | 4848 | 0.010 |
Why?
|
| Hydrazines | 1 | 2002 | 225 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2016 | 7729 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2010 | 3749 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 1997 | 9272 | 0.010 |
Why?
|
| Diagnostic Imaging | 1 | 2014 | 3503 | 0.010 |
Why?
|
| Rabbits | 2 | 1996 | 4894 | 0.010 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2002 | 546 | 0.010 |
Why?
|
| Pulmonary Artery | 1 | 1988 | 1911 | 0.010 |
Why?
|
| Young Adult | 2 | 2018 | 56392 | 0.010 |
Why?
|
| Cohort Studies | 3 | 2009 | 40545 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2013 | 7784 | 0.010 |
Why?
|
| Chronic Disease | 2 | 2009 | 9139 | 0.010 |
Why?
|
| Patient Readmission | 1 | 2013 | 3117 | 0.010 |
Why?
|
| Cell Separation | 1 | 1984 | 1750 | 0.010 |
Why?
|
| Morbidity | 1 | 2004 | 1768 | 0.010 |
Why?
|
| Child | 2 | 2024 | 77637 | 0.010 |
Why?
|
| Crohn Disease | 1 | 1991 | 2304 | 0.010 |
Why?
|
| Indoles | 2 | 1997 | 1841 | 0.010 |
Why?
|
| 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt | 1 | 1996 | 5 | 0.010 |
Why?
|
| Registries | 1 | 2013 | 8090 | 0.010 |
Why?
|
| Blood Platelets | 1 | 1987 | 2509 | 0.010 |
Why?
|
| Hospital Charges | 1 | 1999 | 362 | 0.010 |
Why?
|
| Postoperative Period | 1 | 2002 | 1841 | 0.010 |
Why?
|
| Thromboxane A2 | 1 | 1996 | 93 | 0.010 |
Why?
|
| Infant | 2 | 2013 | 35122 | 0.010 |
Why?
|
| Tunica Media | 1 | 1996 | 112 | 0.010 |
Why?
|
| Prognosis | 2 | 2007 | 29052 | 0.010 |
Why?
|
| Free Radicals | 1 | 1996 | 237 | 0.010 |
Why?
|
| Injury Severity Score | 1 | 1999 | 1014 | 0.010 |
Why?
|
| Aluminum | 1 | 1996 | 152 | 0.010 |
Why?
|
| Culture Media, Conditioned | 1 | 1997 | 537 | 0.010 |
Why?
|
| Knee | 1 | 1997 | 273 | 0.010 |
Why?
|
| Proteins | 1 | 2010 | 6098 | 0.010 |
Why?
|
| Radiation-Sensitizing Agents | 1 | 1997 | 358 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2012 | 11478 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2013 | 5752 | 0.010 |
Why?
|
| Acetylcholine | 1 | 1996 | 619 | 0.010 |
Why?
|
| Algorithms | 1 | 2014 | 13869 | 0.010 |
Why?
|
| Necrosis | 1 | 1998 | 1642 | 0.010 |
Why?
|
| Luciferases | 1 | 1995 | 733 | 0.010 |
Why?
|
| Age Distribution | 1 | 1999 | 2899 | 0.010 |
Why?
|
| Massachusetts | 1 | 2005 | 8660 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1995 | 2050 | 0.010 |
Why?
|
| Lasers | 1 | 1996 | 949 | 0.010 |
Why?
|
| DNA Primers | 1 | 1995 | 2891 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1995 | 4320 | 0.010 |
Why?
|
| Preoperative Care | 1 | 1997 | 2251 | 0.000 |
Why?
|
| Walking | 1 | 1994 | 1182 | 0.000 |
Why?
|
| Incidence | 1 | 2005 | 20948 | 0.000 |
Why?
|
| Phenotype | 1 | 1984 | 16361 | 0.000 |
Why?
|
| Exercise Test | 1 | 1994 | 2074 | 0.000 |
Why?
|
| Hematoma | 1 | 1991 | 758 | 0.000 |
Why?
|
| Colectomy | 1 | 1991 | 680 | 0.000 |
Why?
|
| Hospital Mortality | 1 | 1999 | 5316 | 0.000 |
Why?
|
| Membrane Glycoproteins | 1 | 1995 | 3769 | 0.000 |
Why?
|
| Base Sequence | 1 | 1995 | 12798 | 0.000 |
Why?
|
| Dogs | 1 | 1987 | 3911 | 0.000 |
Why?
|
| Stroke | 1 | 2005 | 9975 | 0.000 |
Why?
|
| Molecular Sequence Data | 1 | 1995 | 18107 | 0.000 |
Why?
|
| Child, Preschool | 1 | 1999 | 40964 | 0.000 |
Why?
|